http://www.novavax.com
Novavax, Inc. Company Intro
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. More...
Industry
Healthcare
Novavax, Inc. Headquaters
21 Firstfield Road
Gaithersburg,20878
United States
Novavax, Inc. Share price
17 May 2023 13:38 GMT
$8.10
0.46 (6.02 %)
Novavax, Inc. Market cap
$648.272 M
WMC RANKING
2023
Novavax, Inc. # 97
BiotechnologyLatest Novavax, Inc. News
20 Sep 2023
Vaccine Adjuvants Market Huge Growth in Future Scope 2023 ...
... Novavax Inc., Merck & Co. Inc., InvivoGen, GlaxoSmithKline PLC, Dynavax Technologies Corporation, CSL Limited, Croda International PLC, Vertellus, Aphios...
20 Sep 2023
Does Novavax Inc. (NVAX) offer a good opportunity for ...
Novavax Inc. (NASDAQ: NVAX) stock jumped 3.64% on Tuesday to $7.68 against a previous-day closing price of $7.41. With 10.58 million shares changed hands,...
20 Sep 2023
Novavax Inc. stock underperforms Wednesday when ...
Shares of Novavax Inc. NVAX slid 8.20% to $7.05 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ...
WMC Market Score
WMC Market to Revenue Score
Novavax, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Novavax, Inc. | USD | $919,450 | $1,521,904 | $-615,114 | $6,483M | 97 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Novavax, Inc. Social Followers vs Top 4 Industry Competitors
Novavax, Inc. Post vs Top 4 Industry Competitors
Novavax, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Novavax, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Novavax, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Novavax, Inc. | 10.00 | 41.05 | 0.14 | 0 | 0 | 0 | 17.77 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
